EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

…, R Landewé, J Bijlsma, G Burmester… - Annals of the …, 2017 - ard.bmj.com
Recent insights in rheumatoid arthritis (RA) necessitated updating the European League
Against Rheumatism (EULAR) RA management recommendations. A large international …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

…, T Huizinga, JWJW Bijlsma, G Burmester… - Annals of the …, 2010 - ard.bmj.com
Treatment of rheumatoid arthritis (RA) may differ among rheumatologists and currently, clear
and consensual international recommendations on RA treatment are not available. In this …

Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

JS Smolen, FC Breedveld, GR Burmester… - Annals of the …, 2016 - ard.bmj.com
Background Reaching the therapeutic target of remission or low-disease activity has
improved outcomes in patients with rheumatoid arthritis (RA) significantly. The treat-to-target …

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

D Aletaha, T Neogi, AJ Silman, J Funovits… - Arthritis & …, 2010 - Wiley Online Library
Abstract Objective The 1987 American College of Rheumatology (ACR; formerly, the
American Rheumatism Association) classification criteria for rheumatoid arthritis (RA) have …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

JS Smolen, RBM Landewé, JWJ Bijlsma… - Annals of the …, 2020 - ard.bmj.com
Objectives To provide an update of the European League Against Rheumatism (EULAR)
rheumatoid arthritis (RA) management recommendations to account for the most recent …

[HTML][HTML] European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update

…, N Betteridge, J Braun, G Burmester… - Annals of the …, 2016 - ard.bmj.com
Background Since the publication of the European League Against Rheumatism
recommendations for the pharmacological treatment of psoriatic arthritis (PsA) in 2012, new …

Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial …

SB Cohen, P Emery, MW Greenwald… - Arthritis & …, 2006 - Wiley Online Library
Objective To determine the efficacy and safety of treatment with rituximab plus methotrexate
(MTX) in patients with active rheumatoid arthritis (RA) who had an inadequate response to …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

…, FC Breedveld, M Buch, G Burmester… - Annals of the …, 2014 - ard.bmj.com
In this article, the 2010 European League against Rheumatism (EULAR) recommendations
for the management of rheumatoid arthritis (RA) with synthetic and biological disease …

Treating rheumatoid arthritis to target: recommendations of an international task force

…, FC Breedveld, D Boumpas, G Burmester… - Annals of the …, 2010 - ard.bmj.com
Background Aiming at therapeutic targets has reduced the risk of organ failure in many
diseases such as diabetes or hypertension. Such targets have not been defined for …

Guidelines for musculoskeletal ultrasound in rheumatology

M Backhaus, GR Burmester, TH Gerber… - Annals of the …, 2001 - ard.bmj.com
Within the past decade, musculoskeletal ultrasound (US) has become an established
imaging technique for the diagnosis and follow up of patients with rheumatic diseases. 1–5 …